Trial Condition(s):

Hypertension

Treatment of hypertension with Adalat® in combination with other drugs

Bayer Identifier:

14296

ClinicalTrials.gov Identifier:

NCT01118286

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

Inclusion Criteria
- Previously untreated hypertensive patients starting with combination therapy containing nifedipine
or
 - Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy
Exclusion Criteria
- None. Exclusion criteria are defined by contraindications and precautions as stated in the local product information.

Trial Summary

Enrollment Goal
4497
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Adalat CC (Nifedipine, BAYA1040)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Russia

Status
Completed
 
Locations

Investigative Site

Many Locations, Pakistan

Status
Completed
 
Locations

Investigative Site

Many Locations, Egypt

Status
Completed
 
Locations

Investigative Site

Many Locations, Morocco

Status
Terminated
 
Locations

Investigative Site

Many Locations, Saudi Arabia

Status
Completed
 
Locations

Investigative Site

Many Locations, Bahrain

Status
Completed
 
Locations

Investigative Site

Many Locations, United Arab Emirates

Status
Completed
 
Locations

Investigative Site

Many Locations, Oman

Status
Completed
 
Locations

Investigative Site

Many Locations, Jordan

Status
Completed
 
Locations

Investigative Site

Many Locations, Lebanon

Status
Completed
 
Locations

Investigative Site

Many Locations, Qatar

Status
Completed
 

Trial Design